After more than 13 years at the helm of Lucasfilm, Kathleen Kennedy is stepping down from the “Star Wars” factory founded by George Lucas.
The Walt Disney Co. announced Thursday that it will now turn to Dave Filoni to steer “Star Wars,” as president and chief creative officer, into its sixth decade and beyond. Filoni, who served as the chief commercial officer of Lucasfilm, will inherit the mantle of one of the movies marquee franchises, alongside Lynwen Brennan, president and general manager of Lucasfilm’s businesses, who will serve as co-president.
Click to Gallery
FILE - Producer Kathleen Kennedy poses upon arrival at the premiere of the film 'Indiana Jones and the Dial of Destiny' June 26, 2023, in London. (Scott Garfitt/Invision/AP, File)
Actor Keri Russell, left, and producer Kathleen Kennedy pose together at the AFI Awards at the Four Seasons in Los Angeles, Friday, Jan. 9, 2026. (AP Photo/Chris Pizzello)
FILE - Film producer Kathleen Kennedy, left, and director Dave Filoni are welcomed by R2-D2 and C-3PO, right, as they appear on stage during a fan convention called the Star Wars Celebration in Chiba, near Tokyo, April 18, 2025. (AP Photo/Hiro Komae, File)
FILE - Kathleen Kennedy, winner of the BAFTA Fellowship, poses with her award backstage at the BAFTA Film Awards in central London, Feb. 2, 2020. (Photo by Joel C Ryan/Invision/AP, File)
“When George Lucas asked me to take over Lucasfilm upon his retirement, I couldn’t have imagined what lay ahead,” said Kennedy. “It has been a true privilege to spend more than a decade working alongside the extraordinary talent at Lucasfilm."
Kennedy, Lucas’ handpicked successor, had presided over the ever-expanding science-fiction world of “Star Wars” since Disney acquired it in 2012. In announcing Thursday's news, Bob Iger, chief executive officer of the Walt Disney Co. called her “a visionary filmmaker.”
Kennedy oversaw a highly lucrative but often contentious period in “Star Wars” history that yielded a blockbuster trilogy and acclaimed streaming spinoffs such as “The Mandalorian” and “Andor,” yet found increasing frustration from longtime fans.
Under Kennedy’s stewardship, Lucasfilm amassed more than $5.6 billion in box office and helped establish Disney+ as a streaming destination — achievements that easily validated the $4.05 billion Disney plunked down for the company. But Kennedy also struggled to deliver the big-screen magic that Lucas captured in the original trilogy from the late 1970s and early 1980s, and her relationship with “Star Wars” loyalists became a saga of its own.
Filoni has established himself almost entirely on the small screen, entering the franchise with the animated series “Star Wars: The Clone Wars” and creating the tepidly received Disney+ series “Ahsoka.” Filoni, who first collaborated with Lucas on “Avatar: The Last Airbender,” has also been an executive producer on “The Mandalorian,” “The Book of Boba Fett” and “Skeleton Crew.”
Both will report to Alan Bergman, Disney Entertainment co-chairman.
“From Rey to Grogu, Kathy has overseen the greatest expansion in Star Wars storytelling on-screen that we have ever seen,” said Filoni. “I am incredibly grateful to Kathy, George, Bob Iger, and Alan Bergman for their trust and the opportunity to lead Lucasfilm in this new role, doing a job I truly love. May the Force be with you.”
Before joining Lucasfilm, Kennedy was one of Hollywood’s most successful producers ever. In 1981, she co-founded Amblin Entertainment with Steven Spielberg and her eventual husband, Frank Marshall. She produced “E.T.,” “Indiana Jones and the Temple of Doom,” “Jurassic Park” and the “Back to the Future” trilogy.
At Lucasfilm, her biggest hit came at the start, with 2015’s “Star Wars: The Force Awakens.” The J.J. Abrams-directed film grossed more than $2 billion worldwide. But the subsequent installment, Rian Johnson’s “The Last Jedi” (2017), was bitterly divisive. The third film, Abrams’ “The Rise of Skywalker” (2019), was widely panned by critics and fans, alike.
After “The Rise of Skywalker,” “Star Wars” went dark on the big screen despite a litany of announced projects. The dry spell is set to be broken in May by Jon Favreau’s “The Mandalorian & Grogu.” The intervening years have been marked by streaming successes in “The Mandalorian” and “Andor,” but the future of “Star Wars” has felt increasingly uncertain.
Struggles over tone and vision have been frequent. The 2018 Han Solo spinoff “Solo: A Star Wars Story” saw its directors, Phil Lord and Christopher Miller, fired during production and replaced by Ron Howard. Most found the mixed-and-matched result blandly disappointing.
More recently, Adam Driver, who played Kylo Ren/Ben Solo in the most recent “Star Wars” trilogy,” divulged to The Associated Press last year that he and Steven Soderbergh had developed a Ben Solo film with Kennedy and Lucasfilm’s support for two years before Disney chief Bob Iger nixed it. Fans were so irate that a plane was flown over Disney’s Burbank studios with a banner reading “Save ‘The Hunt for Ben Solo.’”
Instead, the only “Star Wars” movie of Kennedy’s stewardship to win widespread and prevailing approval from fans was arguably 2016’s “Rogue One.” Gareth Edwards’ spinoff was also a troubled production, leading to Tony Gilroy, eventual creator of “Andor,” overseeing reshoots. Yet despite that, “Rogue One” — taking place within “Star Wars” but outside of the main Jedi storyline — might be the only film of Kennedy’s “Star Wars” reign that managed to both stay true to the space odyssey’s tone and to break new ground.
Kennedy's fingerprints will be on many of coming “Star Wars” projects for years to come. That includes Shawn Levy's “Star Wars: Starfighter,” with Ryan Gosling, due out in May 2027, and a fleet of other projects in various stages of development.
FILE - Producer Kathleen Kennedy poses upon arrival at the premiere of the film 'Indiana Jones and the Dial of Destiny' June 26, 2023, in London. (Scott Garfitt/Invision/AP, File)
Actor Keri Russell, left, and producer Kathleen Kennedy pose together at the AFI Awards at the Four Seasons in Los Angeles, Friday, Jan. 9, 2026. (AP Photo/Chris Pizzello)
FILE - Film producer Kathleen Kennedy, left, and director Dave Filoni are welcomed by R2-D2 and C-3PO, right, as they appear on stage during a fan convention called the Star Wars Celebration in Chiba, near Tokyo, April 18, 2025. (AP Photo/Hiro Komae, File)
FILE - Kathleen Kennedy, winner of the BAFTA Fellowship, poses with her award backstage at the BAFTA Film Awards in central London, Feb. 2, 2020. (Photo by Joel C Ryan/Invision/AP, File)
WASHINGTON (AP) — President Donald Trump on Thursday announced the outlines of a health care plan he wants Congress to take up as Republicans have faced increasing pressure to address rising health costs after lawmakers let subsidies expire.
The cornerstone is his proposal to send money directly to Americans for health savings accounts so they can handle insurance and health costs as they see fit. Democrats have rejected the idea as a paltry substitute for the tax credits that had helped lower monthly premiums for many people.
“The government is going to pay the money directly to you,” Trump said in a taped video the White House released to announce the plan. “It goes to you and then you take the money and buy your own health care.”
Trump's plan also focuses on lowering drug prices and requiring insurers to be more upfront with the public about costs, revenues, rejected claims and wait times for care.
Trump has long been dogged by his lack of a comprehensive health care plan as he and Republicans have sought to unwind former President Barack Obama’s signature legislation, the Affordable Care Act. Trump was thwarted during his first term in trying to repeal and replace the law.
When he ran for president in 2024, Trump said he had only “concepts of a plan” to address health care. His new proposal, short on many specifics, appeared to be the concepts of a plan.
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, described it to reporters on a telephone briefing as a “framework that we believe will help Congress create legislation.”
A White House official who was not authorized to speak publicly and described some details on condition of anonymity said the administration had been discussing the proposal with allies in Congress, but was unable to name any lawmakers who were working to address the plan.
Sen. Bill Cassidy of Louisiana, the Republican chair of the Senate health committee, said in a social media post praising Trump's plan that his committee “has and will take action on the President's affordability agenda.”
The White House did not offer any details about how much money it envisioned being sent to consumers to shop for insurance, or whether the money would be available to all “Obamacare” enrollees or just those with lower-tier bronze and catastrophic plans.
The idea mirrors one floated among Republican senators last year. Democrats largely rejected it, saying the accounts would not be enough to cover costs for most consumers. Currently, such accounts are used disproportionately by the wealthiest Americans, who have more income to fund them and a bigger incentive to lower their tax rate.
White House press secretary Karoline Leavitt was asked Thursday whether the president could guarantee that under his plan, people would be able to cover their health costs. She did not directly answer, but said, “If this plan is put in place, every single American who has health care in the United States will see lower costs as a result.”
Enhanced tax credits that helped reduce the cost of insurance for the vast majority of Affordable Care Act enrollees expired at the end of 2025 even though Democrats had forced a 43-day government shutdown over the issue.
Sen. Bernie Moreno, R-Ohio, has been leading a bipartisan group of 12 senators trying to devise a compromise that would extend those subsidies for two years while adding new limits on who can receive them. That proposal would create the option, in the second year, of a health savings account that Trump and Republicans prefer.
The White House official denied that Trump was closing the door completely on those bipartisan negotiations, and said the White House preferred to send money directly to consumers.
Trump’s plan comes months after the Republicans’ big tax and spending bill last year cut more than $1 trillion over a decade in federal health care and food assistance, largely by imposing work requirements on those receiving aid and shifting certain federal costs to the states.
Democrats have blasted those cuts as devastating for vulnerable people who rely on programs such as Medicaid for their health care. The GOP bill included an infusion of $50 billion over five years for rural health programs, an amount experts have said is inadequate to fill the gap in funding.
The White House said Trump's new proposal will seek to bring down premiums by fully funding cost-sharing reductions, or CSRs, a type of financial help that insurers give to low-income ACA enrollees on silver-level, or mid-tier plans.
From 2014 until 2017, the federal government reimbursed insurance companies for CSRs. In 2017, the first Trump administration stopped making those payments. To make up for the lost money, insurance companies raised premiums for silver-level plans. That ended up increasing the financial assistance many enrollees got to help them pay for premiums.
As a result, health analysts say that while restoring money for CSRs would likely bring down silver-level premiums, as Trump says, it could have the unwelcome ripple effect of increasing many people’s net premiums on bronze and gold plans.
Oz said Trump's plans also seeks to have certain medications made available over the counter instead of by prescription if they are deemed safe enough. He mentioned higher-dose nonsteroidal anti-inflammatory drugs and peptic ulcer drugs as two examples.
It was unclear whether the White House is asking Congress to take steps to make more prescription drugs available over the counter. For decades, the Food and Drug Administration has had the ability to do that.
The heartburn drug Prilosec, as well as numerous allergy medications, are among those the FDA has approved for over-the-counter sales. The FDA only approves such changes if studies show patients can safely take the drug after reading the package labeling. Companies must apply for the switch.
The White House said Trump’s plan would also codify his efforts to lower drug prices by tying prices to the lowest price paid by other countries.
Trump has already struck deals with a number of drugmakers to get them to lower the prices. As part of that, the drugmakers have agreed to sell pharmacy-ready medicines directly to consumers who can shop online at the White House's website for selling drugs directly to consumers, TrumpRx.gov.
TrumpRx did not yet have any drugs listed on Thursday. Oz said drugs will be available on the website at the end of the month.
AP Health Writer Matthew Perrone contributed to this report.
White House press secretary Karoline Leavitt speaks with reporters in the James Brady Press Briefing Room at the White House, Thursday, Jan. 15, 2026, in Washington. (AP Photo/Alex Brandon)
President Donald Trump speaks at the Detroit Economic Club, Tuesday, Jan. 13, 2026 in Detroit. (AP Photo/Ryan Sun)
